pdufa.bio
HomeReadouts › September 2027

September 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for September 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← August 2027October 2027 →
14 readouts
BHVN · Sep 2027 (est.)
BHV-1300: Graves Disease
CHRS · Sep 2027 (est.)
CHS-1420: Hepatocellular Carcinoma
Awaiting data
CSTL · Sep 2027 (est.)
FCX-007: Dystrophic Epidermolysis Bullosa
Awaiting data
HUMA · Sep 2027 (est.)
Human Acellular Vessel: Trauma
Awaiting dataupdated 32mo ago
IMVT · Sep 2027 (est.)
IMVT-1402: Rheumatoid Arthritis
Awaiting data
SMMT · Sep 2027 (est.)
Ivonescimab: Metastatic Esophageal Adenocarcinoma
TLSI · Sep 2027 (est.)
Pembrolizumab: Locally Advanced Pancreatic Adenocarcinoma
Awaiting dataupdated 12mo ago
UPB · Sep 2027 (est.)
Verekitug: Severe Asthma
Awaiting data
AGEN · Sep 2027 (est.)
Botensilimab: Metastatic Colorectal Cancer
Awaiting dataupdated 10mo ago
INCY · Sep 2027 (est.)
Corticosteroids: Chronic Graft-versus-host-disease
CNTA · Sep 2027 (est.)
cleminorexton: Narcolepsy Type 1
IVA · Sep 2027 (est.)
IVA337: NASH - Nonalcoholic Steatohepatitis
Awaiting data
MAIA · Sep 2027 (est.)
6-Thio-2'-Deoxyguanosine: Carcinoma, Non-Small-Cell Lung
Awaiting data
VNDA · Sep 2027 (est.)
Tradipitant: Motion Sickness
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).